POLRMT and B-cell non-Hodgkin lymphoma: These results define high rates of mitochondrial translation enabled by Tfam expression as an essential requirement for the development of B cell lymphoma and show the therapeutic potential of POLRMT and mitochondrial translation inhibition in human disease.